Aktuelles

Für den Lifestraem bitte hier anmelden: www.landtag.nrw.de/home/aktuelles-presse/parlaments-tv/antrag-auf-zugang-zum-livestream.html

Berlin, 08. Juni 2021. Am 10. Juni 2021 beschäftigt sich der Landtag NRW in einer öffentlichen Anhörung des Ausschusses für Arbeit, Gesundheit und Soziales mit dem Krankheitsbild Myalgische Enzephalomyelitis (MEMyalgische Enzephalomyelitis
> mehr Info), auch Chronisches Fatigue Syndrom…

Objective

To characterize the symptom profile and time course in patients with Long COVID, along with the impact on daily life, work, and return to baseline health.

Design

International web-based survey of suspected and confirmed COVID-19 cases with illness lasting over 28 days and onset prior to June 2020.

Setting

Survey distribution via online COVID-19 support groups and social media …

Inhalt:

- Homepage

- Zusammenarbeit mit anderen Patientenorganisationen MEMyalgische Enzephalomyelitis
> mehr Info/CFSChronic Fatigue Syndrome
> mehr InfoMyalgische Enzephalomyelitis / Chronic Fatigue Syndrome
> mehr Info

- Informationen des Vorstandes

- Sonstiges

DecodeME's Dr Veronique Vitart, Dr Shona Kerr and Professor Chris Ponting are among a group of researchers who have just published a study in the top science journal Nature on the role that genetics plays in severe Covid-19.

Using the same technique that will power DecodeME, they found that people with particular DNA differences were more likely to end up in intensive care with Covid-19. The…

Dunedin researchers have smashed the myth that chronic fatigue syndrome is only in the head.

For decades, people with myalgic encephalomyelitis (MEMyalgische Enzephalomyelitis
> mehr Info), also commonly known as chronic fatigue syndrome (CFSChronic Fatigue Syndrome
> mehr Info) and once as "Tapanui Flu", were labelled as depressed or told their symptoms were all in their heads.

However, two four-year studies by the University of Otago’s Emeritus Professor Warren Tate,…

(A) Epigenetic code dynamics

(B) Neuro-inflammation

(C) Energy production

CellTrend bietet ein Test-Panel für POTS-Patienten an. Neben den bei der CFSChronic Fatigue Syndrome
> mehr Info-Diagnostik aufgeführten Tests umfasst dieses Panel auch die Testung von anti-muskarinergen Acetylcholin Rezeptor 1 (M1)-Antikörpern, anti-muskarinergen Acetylcholin Rezeptor 2 (M2)-Antikörpern, anti-muskarinergen Acetylcholin Rezeptor 5 (M5)-Antikörpern, sowie die Testung von Alpha-1 adrenergen Rezeptor Auto-Antikörpern…